216 related articles for article (PubMed ID: 15375504)
21. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
Zhang J; Zheng Y; Wang Y; Tong H
J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
[TBL] [Abstract][Full Text] [Related]
22. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
RaschellĂ G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
23. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
Cheung KJ; Mitchell D; Lin P; Li G
Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
[TBL] [Abstract][Full Text] [Related]
24. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
[TBL] [Abstract][Full Text] [Related]
25. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.
Chen L; Matsubara N; Yoshino T; Nagasaka T; Hoshizima N; Shirakawa Y; Naomoto Y; Isozaki H; Riabowol K; Tanaka N
Cancer Res; 2001 Jun; 61(11):4345-9. PubMed ID: 11389058
[TBL] [Abstract][Full Text] [Related]
26. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
27. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
28. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
Tallen G; Riabowol K; Wolff JE
Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
[TBL] [Abstract][Full Text] [Related]
29. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
[TBL] [Abstract][Full Text] [Related]
30. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
31. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; BĂ©nard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
32. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
33. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
34. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
Wachowiak R; Fiegel HC; Kaifi JT; Quaas A; Krickhahn A; Schurr PG; Erttmann R; Schachner M; Kluth D; Sauter G; Izbicki JR
Ann Surg Oncol; 2007 Dec; 14(12):3575-80. PubMed ID: 17917782
[TBL] [Abstract][Full Text] [Related]
35. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
[TBL] [Abstract][Full Text] [Related]
36. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
37. Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues.
Walzak AA; Veldhoen N; Feng X; Riabowol K; Helbing CC
Exp Cell Res; 2008 Jan; 314(2):273-85. PubMed ID: 17720155
[TBL] [Abstract][Full Text] [Related]
38. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
40. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]